Skip to main content

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

Recruiting · Phase 3 · NCT05723198

Conditions: Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical

At a glance

Research payments reported, 2025
$829,933
U.S. investigators named
37
Sites paid
35
Planned or actual enrollment
595

About the trial

Sponsor
Eli Lilly and Company
Tested
Baricitinib (drug), Placebo (drug)
Dates
Started 2023-02-27; completion 2033-09
Results posted
Not yet

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age. The study is divided into 4 periods, a 5-week Screening period, a 36-week Double-Blind Treatment Period, an approximately 2-year Long-term Extension (LTE) Period, and a 4-week Post-treatment Follow-up period. Some individuals may be eligible to receive treatment after completing the LTE, for a maximum of 180 weeks.

From ClinicalTrials.gov, last updated 2026-11-04. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $829,933 in research payments for this study in 2025 (43 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Texas Dermatology and Laser Specialists $104,732
  • Northwestern University $78,083
  • Medical University of South Carolina $58,248
  • J Robert West MD Inc $53,965
  • Dermassociates PC $48,017
  • Solutions Through Advanced Research $39,860
  • Uh Cleveland Medical Center, OH $33,474
  • Qcare Site Services Inc $31,601
  • $30,174
  • Board of Regents of the Univ of Wisconsin Systm $30,094
  • Virginia Clinical Research Inc $30,060
  • Kaiser Foundation Hospital-Santa Clara, CA $29,289
  • Biomedical Research Alliance of New York $28,471
  • Pediatric Skin Research LLC $24,462
  • Sunrise Medical Research Inc $21,074
  • Complete Dermatology $20,354
  • Skin Specialists PC $19,996
  • University of Utah Hospital and Clinics, UT $18,400
  • Nw Dermatology Institute $17,196
  • Vital Prospects Clinical Research Inst PC $15,940
  • Dawes Fretzin Clinical Research Group LLC $11,680
  • Total Skin and Beauty Dermatology Center PC $11,472
  • Dermatologic Surgical Specialists $10,751
  • Elias Research Associates LLC $8,835
  • Northshore University Healthsystem - Evanston Hospital, IL $8,659
  • Regents of the University of California $6,884
  • Investigate MD, LLC $6,755
  • Regents of the University of Minnesota $6,110
  • Cincinnati Children's Hospital Medical Center, OH $5,900
  • The Pennsylvania Centre for Dermatology LLC $5,405
  • Dermatology Research Associates Inc $4,230
  • International Clinical Research $3,647
  • Forward Clinical Trials Inc $3,318
  • Djl Clinical Research PLLC $2,400
  • Skin Care Research LLC $200
  • Dermatology Treatment and Research Center PA $200

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.